Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma-Reference-Cited by-同舟云学术

Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma

Published:2015-05-02 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Rozera Carmela,Cappellini Giancarlo Antonini,D’Agostino Giuseppina,Santodonato Laura,Castiello Luciano,Urbani Francesca,Macchia Iole,Aricò Eleonora,Casorelli Ida,Sestili Paola,Montefiore Enrica,Monque Domenica,Carlei Davide,Napolitano Mariarosaria,Rizza Paola,Moschella Federica,Buccione Carla,Belli Roberto,Proietti Enrico,Pavan Antonio,Marchetti Paolo,Belardelli Filippo,Capone Imerio

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0473-5.pdf

Reference62 articles.

1. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.

2. Eggermont AMM, Kirkwood JM. Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years? Eur J Cancer. 2004;40:1825–36.

3. Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist. 2011;16:5–24.

4. Eggermont AMM. Advances in systemic treatment of melanoma. Ann Oncol. 2010;21 Suppl 7:vii339–44.

5. Jang S, Atkins MB. Which drug, and when, for patients with BRAF-mutant melanoma? Lancet Oncol. 2013;14:e60–9.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22

2. Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha;Frontiers in Oncology;2023-05-18

3. Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice;Journal of Experimental & Clinical Cancer Research;2021-10-08

4. Detection and viability of murine NK cells in vivo in a lymphoma model using fluorine‐19 MRI;NMR in Biomedicine;2021-08-18

5. Preclinical models and technologies to advance nanovaccine development;Advanced Drug Delivery Reviews;2021-05